Fibrinolytic (Plasmin) Therapy of Experimental Coronary Thrombi with Alteration of the Evolution of Myocardial Infarction | Zendy

Paul Ruegsegger | Zendy; Irwin Nydick | Zendy; Robert C. Hutter | Zendy; Alvin H. Freiman | Zendy; Nils U. Bang | Zendy; Eugene E. Cliffton | Zendy; John S. LaDue | Zendy

Open Access

Fibrinolytic (Plasmin) Therapy of Experimental Coronary Thrombi with Alteration of the Evolution of Myocardial Infarction

Author(s) -

Paul Ruegsegger,

Irwin Nydick,

Robert C. Hutter,

Alvin H. Freiman,

Nils U. Bang,

Eugene E. Cliffton,

John S. LaDue

Publication year - 1959

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.19.1.7

Subject(s) - medicine , plasmin , myocardial infarction , cardiology , coronary thrombosis , thrombosis , fibrinolytic therapy , infarction , fibrinolysis , biochemistry , chemistry , enzyme

To explore the possibilities of fibrinclytic therapy of coronary thrombosis, experimental studies were carried out to document lysis of coronary thrombi and to investigate the effect of fibrinolytic blood upon myocardial infarction. Serum-induced coronary thrombi were produced by a new technic and were followed by serial coronary arteriography. Control animals were compared to animals in which significant fibrinolytic activity had been induced by systemic infusions of plasmin. Tissue studies suggest that plasmin may change the evolution of early infarction. Whether these changes will ultimately result in salvage of ischemic tissue will be determined by studies now in progress.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research